Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Glycerol Phenylbutyrate (PBA) Use in Endoplasmic Reticulum Stress Reduction in ATF6-/- Patients

NCT04041232 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04041232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04041232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Glycerol Phenylbutyrate (PBA) Use in Endoplasmic Reticulum Stress Reduction in ATF6-/- Patients
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Suspended
Start date
April 8, 2025
Completion date
August 31, 2027
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achromatopsia, achromatopsia 7